In this study, we firstly demonstrated that PITX2 was frequently upregulated in ovarian cancers particularly in high-grade and clear cell subtype of ovarian cancer using Q-PCR, Western blot and IHC analyses. This evidence concerns the gene PITX2 and ovarian carcinoma.